Replies to post #7496 on BioCorRx Inc. (BICX)

[Pip611]

VIVITROL is injectable naltrexone produced by Alkermes plc (ALKS). ALKS has a 7.5 billion dollar market cap and is estimated to do about 185mm in net sales this year of VIVITROL. If BICX could produce a better version of injectable naltrexone with TheraKine, it could make them a buyout target for Alkermes.

If you look at the last 2 PRs about FDA approval and the deal with TheraKine to produce injectable naltrexone, it has buy out written all over it. Only 500mm price tag on BICX would be $3 per share!

https://www.vivitrol.com/

https://finance.yahoo.com/quote/alks?ltr=1

JMHO